Shanghai Xinke Pharmaceutical Co., Ltd.

Shanghai Xinke Pharmaceutical Co., Ltd. is located in the Xinzhuang Industrial Zone of Shanghai and was officially put into operation in 1995. The main business scope of the company is to develop and produce radioactive drugs for internal use (radioactive imaging agents, urea [14C] breath test capsules and their kits, radioactive seed sources for treating cancer), provide scientific and technological consulting, technical services, and sell self-produced products.

For nearly 25 years since its establishment, the company has always adhered to the principle of "serving differently", continuously striving and exploring development. It has introduced advanced technology and management models from Xinke International in the United States, filling the gap in the centralized production and supply of unregulated radioactive drugs in China and breaking through the traditional mode of radioactive drug supply in China. In terms of company qualifications, the radioactive production license, radioactive business license, GMP certificate, etc. have all been successfully passed.

Continuously awarded the title of Top 100 Enterprises in Shanghai Xinzhuang Industrial Zone from 2016 to 2018. From 2018 to 2020, it was awarded the title of "Specialized, Refined, Unique and New" small and medium-sized enterprise by the Shanghai Economic and Information Commission.